Ingevity Q3 total net sales $362.1M (-4% YoY); adj EBITDA $121.2M (+14%); revises FY guidance

Ingevity Corp

2025-Q3 EPS reported -$2.27 revenue$912,500,000

Net income $43.5M, EPS $1.18; continuing ops net income $40.8M, EPS $1.10.
Total adjusted EBITDA $121.2M (+14% YoY); margin improved to 33.5%.
Announced sale of majority of Industrial Specialties and N. Charleston refinery for $110M; close by early 2026; reported as discontinued ops.
Operating cash flow $129.7M, free cash flow $117.8M; $25M share repurchases; net leverage 2.7x.
Revised FY guidance: total net sales $1.25B-$1.35B, total adj EBITDA $390M-$405M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.